MedTrace Logo

Docosahexaenoic Acid on Breath Holding Spells in Children

NCT03965988 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2019-05-29

No results posted yet for this study

Summary

DHA on Breath Holding Spells

Conditions

  • Breath Holding Attack

Interventions

DRUG

DHA

Docosahexaenoic acid

DRUG

Placebo

Placebo

Sponsors & Collaborators

  • Sherief Abd-Elsalam

    lead OTHER

Principal Investigators

  • Amira Darwish, Lecturer · Tanta University - Faculty of Medicine

  • Abeer Salamah, MD · Tanta University - Faculty of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
1 Month
Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-01
Primary Completion
2028-11-30
Completion
2028-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03965988 on ClinicalTrials.gov